首页> 外文OA文献 >Reductions in headache impact test (HIT-6) scores with fremanezumab and erenumab among patients with episodic migraine (EM) and 2–4 prior treatment failures: A network meta-analysis

【2h】

Reductions in headache impact test (HIT-6) scores with fremanezumab and erenumab among patients with episodic migraine (EM) and 2–4 prior treatment failures: A network meta-analysis

机译：患有弗里蒙扎姆布和Erenumab的头痛影响试验（HIT-6）分数减少（EM）和2-4个先前治疗的故障：网络元分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P. Pozo-Rosich; O. Patterson-Lomba; F. Mu; S. Thompson; S. Gandhi; T. Doctor; S. Bousleiman; R. Yang; J.M. Cohen;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine Who Have Failed At least One Prior Preventive Migraine Medication: Results of a 1-Year Study [J] . Brandes J., Smith T. R., Cohen J. M., Headache . 2019,第Suppla1期

机译：Fremanezumab对患者反应率的长期影响，急性头痛药物用途和患者患者的患者失败了至少一个预防性偏头痛药物的药物：1年的研究结果
2. Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary [J] . Shin Hae Eun, Park Jeong Wook, Kim Yeong In, Journal of Clinical Neurology . 2008,第4期

机译：偏头痛患者的头痛影响力测试6（HIT-6）得分：从头痛日记中测得的他们与残疾的关系
3. Long-Term Impact of Fremanezumab on Headache-Related Disability, Quality of Life, and Patient Satisfaction in Episodic Migraine and Chronic Migraine [J] . Cohen J. M., Saikali N. P., Yang R., Headache . 2019,第Suppla1期

机译：Fremanezumab对与头痛相关的残疾，生活质量和患者满意度的长期影响，患有巨头偏头痛和慢性偏头痛
4. A Systematic Review and Network Meta-Analysis of Emergency Department Migraine Treatment [D] . Westafer, Lauren M. 2018

机译：急诊科偏头痛治疗的系统综述与网络荟萃分析
5. Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary [O] . Hae Eun Shin, Jeong Wook Park, Yeong In Kim, 2008

机译：偏头痛患者的头痛影响力测试6（HIT-6）得分：从头痛日记中测得的他们与残疾的关系
6. Reduction in acute headache medication use with fremanezumab in chronic migraine patients by prior migraine preventive treatment use: Subgroup analysis of the HALO CM study [O] . R. Stark, J.M. Cohen, R. Yang, 2019

机译：通过先前的偏头痛预防治疗用途减少慢性偏头痛患者的Fremanezumab：Halo CM研究的亚组分析

Reductions in headache impact test (HIT-6) scores with fremanezumab and erenumab among patients with episodic migraine (EM) and 2–4 prior treatment failures: A network meta-analysis

著录项

引文网络

相似文献

相关主题

期刊订阅